Click for next page ( 97

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 96
Appendix B Public Meeting Agenda July 1 1' 2002 Immunization Safety Review Committee SV40 Contamination of Polio Vaccine and Cancer National Academy of Sciences Main Building Lecture Hall, 2100 C St, NW Washington DC 8:45-9:00 am Welcome and Opening Remarks Marie McCormick, MD, ScD Committee Chair 9:00-9:15 am Brief History and Important Questions William Egan, PhD, CBER, FDA 9:15-11:15 am Epidemiological Evidence Regarding Causality Between SV40-contaminated Polio Vaccines and Human Cancers Howard Striclder, MO, MPH Albert Einstein College of Medicine Susan Fisher, MD, University of Rochester Eric Engels' MD, ASH, NCI, NIH 11:15-11:30 am Break 96

OCR for page 96
APPENDIX B 97 11:30-12:45 pm SV40 Detection and Transmission Keerti Shah, MD, DrPH Johns Hopkins Bloomberg School of Public Health Jeffrey Kopp, MD, NIDDK, NIH 12:45-1:45 pm Lunch 1:45-4:15 pm The Presence and Mechanisms of SV40 in Human Cancers Janet Butel, PhD Baylor University School of Medicine Michele Carbone, MD, PhD Loyola University School of Medicine 4:15pm 5:30 pm Discussion and Public Comment Adjourn